`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`————————————————
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`————————————————
`
`ACRUX DDS PTY LTD., ACRUX LIMITED, and
`ARGENTUM PHARMACEUTICALS LLC,
`Petitioners
`
`v.
`
`KAKEN PHARMACEUTICAL CO., LTD. and
`VALEANT PHARMACEUTICALS INTERNATIONAL, INC.
`Patent Owners.
`
`————————————————
`
`Case IPR2017-00190
`Patent 7,214,506
`
`————————————————
`
`
`DECLARATION OF WILLIAM A. RAKOCZY IN SUPPORT OF
`ACRUX’S UNOPPOSED MOTION
`FOR PRO HAC VICE ADMISSION IN IPR2017-00190
`
`
`
`I, William A. Rakoczy, declare as follows:
`
`1.
`
`I am an experienced litigating attorney with more than twenty (20)
`
`years of experience.
`
`2.
`
`3.
`
`I have been litigating patent cases for at least twenty (20) years.
`
`I am a member in good standing of the Illinois State Bar and am
`
`admitted to practice in the Supreme Court of the United States, United States Court
`
`of Appeals for the Federal Circuit, United States Court of Appeals for the Seventh
`
`Circuit, United States Court of Appeals for the District of Columbia Circuit,
`
`United States Court of Appeals for the Fourth Circuit, United States Court of
`
`Appeals for the Third Circuit, and the United States District Courts for the
`
`Northern District of Illinois, Western District of Wisconsin, District of Columbia,
`
`Western District of Michigan, and District of Colorado.
`
`4.
`
`I have never been suspended or disbarred from practice before any
`
`court or administrative body.
`
`5.
`
`I have never had an application for admission to practice before any
`
`court or administrative body denied.
`
`6.
`
`I have had no sanctions or contempt citations imposed against me by
`
`any court or administrative body.
`
`7.
`
`I am familiar with the subject matter at issue in this proceeding.
`
`Specifically, I am familiar with the patent-at-issue in this proceeding—U.S. Patent
`
`
`
`1
`
`
`
`No. 7,214,506 (“the ‘506 patent”). I am advising Acrux on patent matters relating
`
`to the subject matter claimed in ‘506 patent and the prior art raised in the Petition.
`
`8.
`
`I have read and will comply with the Office Patent Trial Practice
`
`Guide and the Board’s Rules of Practice for Trials set forth in Part 42 of the C.F.R.
`
`9.
`
`I agree to be subject to the USPTO Rules of Professional Conduct set
`
`forth in 37 C.F.R. §§11.101 et seq. and to disciplinary jurisdiction under 37 C.F.R.
`
`§11.19(a).
`
`10.
`
`In the last three (3) years, I have applied to appear and have been
`
`admitted pro hac vice in three inter partes review proceedings, Lupin Limited v.
`
`Janssen R&D Ireland, Case IPR2015-01030, Novo Nordisk Inc., v. Nextar
`
`Therapeutics, Case IPR2016-01384, and Mylan Pharmaceuticals Inc. v.
`
`Genentech, Inc. & City of Hope, Case IPR2016-00710.
`
`11.
`
`I hereby declare that all statements made herein of my own
`
`knowledge are true and that all statements made on information and belief are
`
`believed to be true; and further that these statements are made with the knowledge
`
`that willful false statements and the like are punishable by fine or imprisonment, or
`
`both, under Section 1001 of Title 18 of the United States Code and that such
`
`willful false statements may jeopardize the validity of the ‘506 patent.
`
`
`
`
`
`
`
`
`2
`
`
`
`Dated: September 25, 2018 William A. Rakoczy
`
`wrakoezy@rmmslega1.com
`RAKOCZY MOLINO MAZZOCHI SIWIK LLP
`
`6 West Hubbard Street, Suite 500
`
`Chicago, IL 60654
`(312) 222-6301 (telephone)
`(312) 222-6321 (facsimile)
`
`